South Korea: 2.01 Million Foreign Patients and USD 3.1 Billion Forecast by 2033

South Korea’s medical tourism market reached USD 2.0 billion in 2024, with foreign patient arrivals doubling to 2.01 million in the most recent reporting period. The Korea Institute for Industrial Economics and Trade forecasts market growth to USD 3.1 billion by 2033, at a compound annual growth rate of 4.93% from 2025.

This expansion follows the country surpassing one million foreign patients for the first time since launching its international patient initiative. The 2.01 million visitors arrived from 201 countries. The cumulative count of foreign patients over sixteen years now stands at 5.05 million.

Economic Impact and Patient Spending

The Korea Institute for Industrial Economics and Trade estimated total spending by foreign patients and accompanying companions at 12.5 trillion won (approximately USD 8.4 billion). Of this, 3.3 trillion won went toward actual treatment costs.

Government Strategy and Support

The Ministry of Health and Welfare implemented mandatory registration for all medical institutions serving foreign patients. It also introduced compulsory medical malpractice liability insurance requirements for the sector.

In May, the government announced its “Strategy to Facilitate Attraction of International Patients,” setting an initial target of 700,000 foreign patients. Actual arrivals exceeded this target by more than 1.6 times in the most recent measurement period.

Following this overachievement, the government formally designated medical tourism as a strategic national industry. Dedicated support centres were established at Incheon International Airport and Seoul Tourism Plaza to assist arriving patients in their native languages. Enhanced visa facilitation programmes have also reduced entry barriers for patients from key source markets.

Six Medical-Wellness Tourism Convergence Clusters have been designated across the country. The Korea Health Industry Development Institute (KHIDI) actively supports Korean medical institutions in serving foreign patients and promotes the export of Korean medical techniques and services internationally.

Patient Profile and Treatment Areas

Inbound travel is the dominant category for South Korea’s medical tourism market, serving as the primary growth engine for international patient arrivals.

Primary Treatment Categories

• Cosmetic Treatment accounted for 11.2 percent of visits.
• Dermatology attracted 62.9 percent of all foreign patient visits, with over 705,000 international patients seeking dermatological care in one reporting period.
• Traditional Korean Medicine recorded an 84.6 percent increase in foreign patient visits year-on-year.
• Other significant treatment areas include Dental Treatment, Cardiovascular Treatment, Orthopaedic Treatment, Bariatric Surgery, Fertility Treatment, and Ophthalmic Treatment.

Geographic Concentration

Approximately 87.2 percent of all foreign patients receive treatment in Seoul. The capital city hosts 62.5 percent of all medical establishments registered to treat international visitors.

Within Seoul, five districts account for the majority of activity:

• Gangnam led with 377,073 visits.
• Seocho followed with 288,475 visits.
• Mapo recorded 124,447 visits.
• Jung saw 122,222 visits.
• Songpa rounded out the top five.

International medical tourists spent a total of 1.2 trillion won on treatment in Seoul alone using foreign-issued credit cards. This accounted for 85.7 percent of nationwide medical spending by foreign patients. The government’s cluster-based expansion strategy aims to redistribute some of this activity toward provincial centres, particularly for wellness, rehabilitation, and traditional medicine experiences.

Key Institutions and Service Bundling

Key institutions in South Korea’s medical tourism market include Ajou University Medical Center, Banobagi Plastic Surgery, CHA Fertility Center, Injeuniversity Haeundae Hospital, JK Plastic Surgery Center, Keimyung University Dongsan Hospital, Korea Medical Hub, Nasaret International Hospital, Sun Medical Center, and Wonkwang University Hospital.

These organisations increasingly offer comprehensive medical tourism packages. These bundles combine treatment with accommodation, airport transfers, interpreter services, and post-care follow-up.

Market Growth Drivers

Several factors contribute to the industry’s expansion:

• Price competitiveness at quality parity: The average medical tourism patient spends approximately 6.41 million won (USD 4,600) per visit in Korea. This is a fraction of equivalent costs in Western markets, while accessing care from internationally benchmarked institutions.
• Minimal waiting periods: Korean hospitals routinely schedule treatments within days or weeks of initial consultation.
• K-culture amplification: The global popularity of K-pop, K-drama, and K-beauty influences patient decisions, especially for cosmetic and dermatological procedures.
• Elective procedure expansion: Treatments outside standard insurance coverage, such as fertility therapies, gender reassignment procedures, and dental reconstruction, attract financially prepared travellers.

HTN Analysis

South Korea’s medical tourism growth is a direct result of explicit government policy and infrastructure investment. The substantial gap between total patient spending (12.5 trillion won, USD 8.4 billion) and direct treatment costs (3.3 trillion won) indicates that the economic benefits extend significantly beyond clinical revenue. This broader economic impact, including companion spending and other tourism activities, provides a clear rationale for continued state support.

The source highlights a shift towards wellness and traditional medicine, but specific details on the performance of the six designated clusters remain limited. Seoul’s continued dominance, accounting for 87.2 percent of patients and 85.7 percent of spending, suggests that redistributing patient activity to provincial centres will be a long-term challenge requiring sustained effort. The average spend of USD 4,600 per patient, while competitive, also indicates that high-volume, lower-cost procedures like dermatology are central to current patient acquisition.

What to watch

• Performance metrics for the six Medical-Wellness Tourism Convergence Clusters, specifically patient volumes and revenue attributed to these regions outside Seoul.
• Detailed breakdown of patient origin countries for the 2.01 million arrivals; this would inform targeted market development strategies.
• Evolution of average patient spend in categories beyond cosmetic and dermatology, particularly for traditional Korean medicine, to assess the growth in revenue per patient visit.

The news signal for this article was referred from: https://vocal.media/futurism/south-korea-medical-tourism-market-outlook-international-patients-wellness-tourism-and-forecast-to-2034